Unapproved peptide warning
Current TGA safety and compliance material for unapproved peptide products.
Open TGA source →Scientific literature
Evidence profiles, official labels, and research starting points.
Product pages distinguish active ingredients used in approved medicines from unapproved research vials. The source library includes FDA safety material, official prescribing information, PubMed searches, and clinical-trial records.
Official regulator sources
Australia, New Zealand and anti-doping
These sources control over general website summaries for import, supply, medicine approval and competitive sport.
Unapproved peptide health warning
New Zealand medicine, import, possession and supply warning.
Open Medsafe source →Current Prohibited List
World Anti-Doping Agency list and explanatory material.
Open WADA source →Check medications in sport
Medication status search for athletes in Australia, New Zealand and other supported countries.
Open Global DRO →How to read this library: an official label for semaglutide, tirzepatide, tesamorelin, or hCG describes a specific approved product and indication. It does not validate a catalog research vial, a different formulation, or a compounded/bulk product. For most other entries, human safety and interaction data are incomplete.
23 evidence profiles shown